Your browser doesn't support javascript.
loading
Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence.
Tinhofer, I; Jöhrens, K; Keilholz, U; Kaufmann, A; Lehmann, A; Weichert, W; Stenzinger, A; Stromberger, C; Klinghammer, K; Becker, E-T; Dommerich, S; Stölzel, K; Hofmann, V M; Hildebrandt, B; Moser, L; Ervens, J; Böttcher, A; Albers, A; Stabenow, R; Reinecke, A; Budach, V; Hoffmeister, B; Raguse, J D.
Afiliação
  • Tinhofer I; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Radiooncology and Radiotherapy, Charité University Medicine, Berlin, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Berlin, Germany. Electronic ad
  • Jöhrens K; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Institute of Pathology, Charité University Medicine, Berlin, Germany.
  • Keilholz U; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Berlin, Germany; Department of Hematology and Medical Oncology, Charité University Medicine, Berlin, Germany.
  • Kaufmann A; Department of Gynecology, Charité University Medicine, Berlin, Germany.
  • Lehmann A; Institute of Pathology, Charité University Medicine, Berlin, Germany.
  • Weichert W; Institute of Pathology, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stenzinger A; Institute of Pathology, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Stromberger C; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Radiooncology and Radiotherapy, Charité University Medicine, Berlin, Germany.
  • Klinghammer K; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Hematology and Medical Oncology, Charité University Medicine, Berlin, Germany.
  • Becker ET; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Otorhinolaryngology, Charité University Medicine, Berlin, Germany.
  • Dommerich S; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Otorhinolaryngology, Charité University Medicine, Berlin, Germany.
  • Stölzel K; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Otorhinolaryngology, Charité University Medicine, Berlin, Germany.
  • Hofmann VM; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Otorhinolaryngology, Charité University Medicine, Berlin, Germany.
  • Hildebrandt B; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Hematology and Medical Oncology, Charité University Medicine, Berlin, Germany.
  • Moser L; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Radiooncology and Radiotherapy, Charité University Medicine, Berlin, Germany.
  • Ervens J; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Oral and Maxillofacial Surgery, Charité University Medicine, Berlin, Germany.
  • Böttcher A; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Otorhinolaryngology, Charité University Medicine, Berlin, Germany.
  • Albers A; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Otorhinolaryngology, Charité University Medicine, Berlin, Germany.
  • Stabenow R; Common Tumor Registry of the Federal States of Berlin, Brandenburg, Mecklenburg-Western Pomerania, Saxony-Anhalt, Saxony and Thuringia, Germany.
  • Reinecke A; Tumorzentrum Berlin e.V., Berlin, Germany.
  • Budach V; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Radiooncology and Radiotherapy, Charité University Medicine, Berlin, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Berlin, Germany.
  • Hoffmeister B; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Oral and Maxillofacial Surgery, Charité University Medicine, Berlin, Germany.
  • Raguse JD; Charité Comprehensive Cancer Center, Working Group for Head and Neck Cancer, Berlin, Germany; Department of Oral and Maxillofacial Surgery, Charité University Medicine, Berlin, Germany.
Eur J Cancer ; 51(4): 514-521, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25623438

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Carcinoma de Células Escamosas / Fumar / Neoplasias de Cabeça e Pescoço Tipo de estudo: Etiology_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Carcinoma de Células Escamosas / Fumar / Neoplasias de Cabeça e Pescoço Tipo de estudo: Etiology_studies / Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2015 Tipo de documento: Article